Radde I C, Chance G W, Bailey K, O'Brien J, Day G M, Sheepers J
Pediatr Res. 1975 Jul;9(7):564-8. doi: 10.1203/00006450-197507000-00002.
Twenty-six infants weighing less than 1,300 g at birth were divided into pairs according to birth weight (900-1,100 and 1,101-1,300 g) and gestational age ("appropriate" (AGA) = mean 31 weeks; and "small" (SGA) = mean 34 weeks). One member of the pairs was then allocated randomly to one of two treatment regimens with oral sodium bicarbonate. Group A was treated whenever base excess was greater than -8mEq/liter as detected on twice weekly testing and/or when suspected to be acidotic from failure to gain weight. In group B, base excess was maintained within 1 SD of normal (-3.2 +/- 1.7 mEq/liter). The infants received Enfalac 200 ml/kg/24 hr, at 67 cal/100 ml, with vitamin D 400 IU/24 hr added from age 2 weeks. The following measurements were made: daily weight, weekly length, skinfold thickness, head circumference, twice weekly blood pH, PaCO2, base excess, and weekly plasma total calcium, ionic calcium, total magnesium, inorganic phosphorus, and total protein. There were six pairs of each of AGA and SGA infants and two unpaired group A infants. Weekly weight gains did not differ between group A and group B or between AGA and SGA. Length increment was greater in AGA than in SGA babies (0.94 +/- 0.02 vs 0.85 +/- 0.04 cm/week) but not significantly so (P less than 0.1), and in group B babies compared to group A babies (0.973 +/- 0.029 vs 0.83 +/- 0.037 cm/week) (P less than 0.01). Plasma pH was lower in group A (7.23 +/- 0.02) than in group B (7.30 +/- 0.02) and calcium ion activity higher (group A 2.72 +/- 0.04; group B 2.51 +/- 0.06 mEq/liter) between ages 20 and 29 days. Plasma magnesium was higher in group A (1.77 +/- 0.04 mEq/liter) than in group B (1.56 +/- 0.06 mEq/liter) from age 20 to 39 days. Inorganic phosphorus concentrations were consistently higher in group A than in group B, but the differences did not reach significance. Mean total protein concentrations did not rise above 4.5 g/100 ml and tended to be higher in babies of group A than of group B. Bone age was retarded in all babies. Radiographs available for 7 of 13 SGA infants were normal, whereas 6 of 11 radiographs of AGA babies showed some osteoporotic changes.
26名出生体重小于1300克的婴儿按出生体重(900 - 1100克和1101 - 1300克)和胎龄(“适于胎龄”(AGA)=平均31周;“小于胎龄”(SGA)=平均34周)配对。然后将每对中的一名婴儿随机分配到两种口服碳酸氢钠治疗方案之一。A组在每周两次检测中发现碱剩余大于 - 8mEq/升时和/或怀疑因体重未增加而酸中毒时进行治疗。B组将碱剩余维持在正常范围的1个标准差内(-3.2±1.7mEq/升)。婴儿按67千卡/100毫升的能量摄入Enfalac 200毫升/千克/24小时,从2周龄开始每天添加400国际单位维生素D。进行了以下测量:每日体重、每周身长、皮褶厚度、头围、每周两次的血液pH值、PaCO2、碱剩余,以及每周的血浆总钙、离子钙、总镁、无机磷和总蛋白。AGA和SGA婴儿各有6对,A组有2名单独的婴儿。A组和B组之间以及AGA和SGA之间每周体重增加无差异。AGA婴儿的身长增长大于SGA婴儿(0.94±0.02 vs 0.85±0.04厘米/周),但差异不显著(P<0.1),且B组婴儿的身长增长大于A组婴儿(0.973±0.029 vs 0.83±0.037厘米/周)(P<0.01)。在20至29日龄期间,A组的血浆pH值(7.23±0.02)低于B组(7.30±0.02),而钙离子活性较高(A组2.72±0.04;B组2.51±0.06mEq/升)。在20至39日龄期间,A组的血浆镁(1.77±0.04mEq/升)高于B组(1.56±0.06mEq/升)。A组的无机磷浓度始终高于B组,但差异未达到显著水平。平均总蛋白浓度未超过4.5克/100毫升,且A组婴儿往往高于B组婴儿。所有婴儿的骨龄均延迟。13名SGA婴儿中有7名的X线片正常,而11名AGA婴儿的X线片中6名显示有一些骨质疏松改变。